 Business Today | PAB dismisses AstraZeneca appeal on lung cancer drug Business Standard ... has dismissed the company's appeal against refusal of patent to lung cancer drug Gefitinib. The London-headquartered pharmaceutical and biologics company's attempt to seek patent for Gefitinib was first turned down by the Indian Patent office in ... Big Pharma on the backfoot in India India rejects AstraZeneca patent appeal on Iressa Patents appeal board rejects AstraZeneca's plea on cancer drug |
